The transcriptional repressor ID2 supports natural killer cell maturation by controlling TCF1 amplitude
(2021) In Journal of Experimental Medicine 218(6).- Abstract
Gaining a mechanistic understanding of the expansion and maturation program of natural killer (NK) cells will provide opportunities for harnessing their inflammation-inducing and oncolytic capacity for therapeutic purposes. Here, we demonstrated that ID2, a transcriptional regulatory protein constitutively expressed in NK cells, supports NK cell effector maturation by controlling the amplitude and temporal dynamics of the transcription factor TCF1. TCF1 promotes immature NK cell expansion and restrains differentiation. The increased TCF1 expression in ID2-deficient NK cells arrests their maturation and alters cell surface receptor expression. Moreover, TCF1 limits NK cell functions, such as cytokine-induced IFN-γ production and the... (More)
Gaining a mechanistic understanding of the expansion and maturation program of natural killer (NK) cells will provide opportunities for harnessing their inflammation-inducing and oncolytic capacity for therapeutic purposes. Here, we demonstrated that ID2, a transcriptional regulatory protein constitutively expressed in NK cells, supports NK cell effector maturation by controlling the amplitude and temporal dynamics of the transcription factor TCF1. TCF1 promotes immature NK cell expansion and restrains differentiation. The increased TCF1 expression in ID2-deficient NK cells arrests their maturation and alters cell surface receptor expression. Moreover, TCF1 limits NK cell functions, such as cytokine-induced IFN-γ production and the ability to clear metastatic melanoma in ID2-deficient NK cells. Our data demonstrate that ID2 sets a threshold for TCF1 during NK cell development, thus controlling the balance of immature and terminally differentiated cells that support future NK cell responses.
(Less)
- author
- Li, Zhong Yin ; Morman, Rosemary E. ; Hegermiller, Emma ; Sun, Mengxi ; Bartom, Elizabeth T. ; Maienschein-Cline, Mark ; Sigvardsson, Mikael LU and Kee, Barbara L.
- organization
- publishing date
- 2021
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Experimental Medicine
- volume
- 218
- issue
- 6
- article number
- e20202032
- publisher
- Rockefeller University Press
- external identifiers
-
- scopus:85104328484
- pmid:33857289
- ISSN
- 0022-1007
- DOI
- 10.1084/jem.20202032
- language
- English
- LU publication?
- yes
- id
- e6ade786-ac8b-48ac-9197-ed50ae92d03e
- date added to LUP
- 2021-04-26 09:28:55
- date last changed
- 2025-01-13 07:21:11
@article{e6ade786-ac8b-48ac-9197-ed50ae92d03e, abstract = {{<p>Gaining a mechanistic understanding of the expansion and maturation program of natural killer (NK) cells will provide opportunities for harnessing their inflammation-inducing and oncolytic capacity for therapeutic purposes. Here, we demonstrated that ID2, a transcriptional regulatory protein constitutively expressed in NK cells, supports NK cell effector maturation by controlling the amplitude and temporal dynamics of the transcription factor TCF1. TCF1 promotes immature NK cell expansion and restrains differentiation. The increased TCF1 expression in ID2-deficient NK cells arrests their maturation and alters cell surface receptor expression. Moreover, TCF1 limits NK cell functions, such as cytokine-induced IFN-γ production and the ability to clear metastatic melanoma in ID2-deficient NK cells. Our data demonstrate that ID2 sets a threshold for TCF1 during NK cell development, thus controlling the balance of immature and terminally differentiated cells that support future NK cell responses.</p>}}, author = {{Li, Zhong Yin and Morman, Rosemary E. and Hegermiller, Emma and Sun, Mengxi and Bartom, Elizabeth T. and Maienschein-Cline, Mark and Sigvardsson, Mikael and Kee, Barbara L.}}, issn = {{0022-1007}}, language = {{eng}}, number = {{6}}, publisher = {{Rockefeller University Press}}, series = {{Journal of Experimental Medicine}}, title = {{The transcriptional repressor ID2 supports natural killer cell maturation by controlling TCF1 amplitude}}, url = {{http://dx.doi.org/10.1084/jem.20202032}}, doi = {{10.1084/jem.20202032}}, volume = {{218}}, year = {{2021}}, }